Range Low Price High Price Comment
30 days $2.71 $4.34 Thursday, 28th Mar 2024 ALDX stock ended at $3.27. This is 6.17% more than the trading day before Wednesday, 27th Mar 2024. During the day the stock fluctuated 12.15% from a day low at $3.12 to a day high of $3.50.
90 days $2.71 $4.34
52 weeks $1.42 $11.97

Historical Aldeyra Therapeutics prices

Date Open High Low Close Volume
2021-06-16 $11.96 $12.11 $11.52 $11.95 608 294
2021-06-15 $12.30 $12.38 $11.92 $12.04 603 927
2021-06-14 $12.44 $12.54 $12.16 $12.29 883 129
2021-06-11 $12.53 $12.73 $12.27 $12.34 324 252
2021-06-10 $12.58 $12.78 $12.30 $12.41 492 045
2021-06-09 $13.13 $13.18 $12.42 $12.57 1 230 848
2021-06-08 $13.00 $13.06 $12.66 $12.97 734 774
2021-06-07 $12.72 $13.18 $12.63 $12.91 1 084 121
2021-06-04 $12.59 $12.89 $12.49 $12.64 476 756
2021-06-03 $12.50 $12.66 $12.33 $12.49 386 542
2021-06-02 $12.25 $12.54 $12.15 $12.54 640 194
2021-06-01 $12.53 $12.61 $12.21 $12.24 426 625
2021-05-28 $11.89 $12.68 $11.82 $12.52 709 354
2021-05-27 $11.43 $11.87 $11.09 $11.85 661 516
2021-05-26 $11.34 $11.56 $11.22 $11.42 846 788
2021-05-25 $11.40 $11.69 $11.28 $11.36 481 337
2021-05-24 $11.71 $11.79 $11.39 $11.52 496 586
2021-05-21 $11.89 $11.97 $11.65 $11.73 686 841
2021-05-20 $11.54 $11.85 $11.37 $11.82 685 185
2021-05-19 $11.77 $12.14 $11.44 $11.68 952 695
2021-05-18 $12.08 $12.46 $11.95 $12.03 940 446
2021-05-17 $12.14 $12.39 $12.00 $12.10 540 487
2021-05-14 $12.17 $12.37 $11.93 $12.14 668 495
2021-05-13 $12.59 $12.85 $11.85 $12.11 574 476
2021-05-12 $12.45 $12.75 $12.35 $12.48 688 890
Click to get the best stock tips daily for free!

About Aldeyra Therapeutics

Aldeyra Therapeutics Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria... ALDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT